Smailov revealed the reason for inflated science commercialisation figures
Science fund reported commercialisation of research at 43.6%, though audit found only 15.7%. Supreme Audit Chamber chairman Alikhan Smailov explained how using different periods in the calculation inflated the figure.
Фонд-бюро расследования коррупции